Application of nutrition interventions with GLP-1 based therapies: A narrative review of the challenges and solutions
According to the clinical studies behind Sofwave, 88% of patients showed signs of improved or significantly improved facial wrinkles and neckline 12 weeks after their initial Sofwave session
In a review of 12 studies, berberine intake corresponded with reductions in body weight and body mass index, belly fat, and the inflammatory marker C-reactive protein
Ideal candidates for GLP-1 therapy, including Semaglutide and Tirzepatide treatments in NYC, are adults with a BMI of 27 or higher, particularly those with weight-related health issues
Do I need a prescription for GLP-1 medication
Recent studies indicate that by 2030, almost 14% of men and 20% of women around the globe are expected to experience obesity (Federation 2022)